The annual incidence rate for CHD (8 (link)) and stroke was calculated from the Framingham study equations (9 (link)). As four-index cohorts had been defined with specific characteristics, there was a need to calculate the risk based on those profiles. Based on the literature, one out of four CHD events are fatal in the first year (10 (link)), while 60% of them are pre-hospital deaths (11 (link)). Therefore, it was assumed that of those who have a CHD event in the model, 25% die in the first year. Approximately 60% of these deaths were costless as they are pre-hospital deaths. Regarding first-year stroke mortality, the range varies in different resources and is reported from 22 to 34% (12 (link)). For this analysis, the rate was applied from the largest available cohort (13 (link)). Almost 25% of stroke events are fatal in the first year, while half of them occur during the first 28 days. Therefore, it is assumed that although at the end of the cycle, they move to the death state, 40% of the cycle cost should be considered for them. The fatality rate for stroke and CHD survivors was derived from a study that had been done on the Iranian population (14 (link)). The background mortality rate from all causes other than stroke and CHD is calculated by excluding the total death attributed to these two diseases from the Iranian life table1. The total mortality rate of these two events had been calculated in Tehran Lipid and Glucose Study (TLGS). At first, the annual rates were derived from the life table and then the CHD- and stroke-attributed deaths were excluded.
Free full text: Click here